Asthma Trials in Zaragoza, Spain
Conditions / Asthma / Zaragoza, Spain
Asthma has been the subject of sustained clinical investigation across multiple research sites.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03557307 | Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma | COMPLETED | PHASE3 |
| NCT02760329 | Observational Study of Obstructive Lung Disease (NOVELTY) | COMPLETED | — |
| NCT04609878 | Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) | COMPLETED | PHASE3 |
| NCT02924688 | A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma | COMPLETED | PHASE3 |
| NCT00463866 | Local Phase 4 Pan-European SMART Study | COMPLETED | PHASE4 |
| NCT04718103 | A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 |
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 |
| NCT03226392 | Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma | COMPLETED | PHASE3 |
| NCT06748053 | A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03052517 | Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment | TERMINATED | PHASE3 |